All News

Sivelestat significantly reduced the incidence of postoperative ARDS, lowered 90-day mortality, and suppressed inflammatory biomarkers linked to lung injury.

Resmetirom shows sustained quality-of-life gains in MASH and cirrhosis, easing abdominal symptoms and disease worry as liver fat drops.

Risk-based mammography tailors screening to breast cancer risk, reducing false positives and preventing more deaths than age-based screening.

Cost barriers push Latino adults to delay care, raising emergency department visits.

Michael Bernstein, MD, discusses how AI-assisted radiology workflows affect liability, automation bias, and patient safety in diagnostic imaging.

Accountable care experts say the future of value in Medicare will rely on scaling up innovation, emphasizing downstream prevention, and staying alert to waste.

Peter Staley at CROI 2026 on defending 45 years of HIV progress: how clinicians, payers, and advocates can resist—quietly or publicly—and why it matters.

MajesTEC-9 supports moving teclistamab earlier in myeloma treatment, with robust PFS and OS gains over standard care in the second-line setting, notes Roberto Mina, MD.

Patients identified as having a Janus kinase inhibitor responder profile were much more likely to respond positively to the class of atopic dermatitis therapies.

A new nasal spray for patients with chronic spontaneous urticaria could eliminate the need for injectable epinephrine.

The 2026 V-BID Summit showcases strategies to make health care more affordable, equitable, and outcomes-driven.

Short-term anatomical and visual improvements were found when patients used SB15 to treat their macular edema caused by retinal vein occlusion (RVO).

The results are the latest from the multiarm EPCORE-NHL-2 trial, which has studied the bispecific antibody epcoritamab in multiple uses and combinations.

New research links post-Dobbs total abortion bans to higher births and WIC demand, raising safety-net costs and access concerns.

Left bundle-branch pacing significantly lowered the combined risk of death or heart failure hospitalization compared with conventional biventricular pacing.

Early treatment for acute promyelocytic leukemia likely improves mother-baby outcomes, with treatment timing guiding safer delivery.

A mock jury study suggests AI-assisted double reads may reduce perceived radiologist liability in malpractice cases.

Persistent high-level EBNA-1 peptide antibody titers could be used to identify multiple sclerosis (MS) vs neuromyelitis optica spectrum disorder (NMOSD).

A study of 46 million visits finds telemedicine remains above prepandemic levels, but older adults and minority groups are less likely to use virtual care.

The efficacy and safety of efgartigimod in pediatric patients will need to be further validated with future studies.

Ajai Chari, MD, discusses how the results of the MajesTEC-3 trial may translate to a real-world second-line population with multiple myeloma.

Intensive lifestyle programs for childhood obesity can prevent long-term chronic disease.

Federal RHTP funding often misses states with the highest rural mortality and greatest projected Medicaid funding losses, researchers found.

Clinicians must consider patient comorbidities and therapy safety when selecting immunotherapy for cSCC, says Todd Schlesinger, MD.

Noah Greenspan, DPT explains challenges diagnosing long COVID and strategies like pacing, compression, and electrolytes to support recovery.

A deeper understanding of vitiligo's autoimmune mechanisms has fundamentally transformed vitiligo care, explains Susan Taylor, MD.

Phase 3 trials show deucravacitinib, the first TYK2 inhibitor approved for adults with active psoriatic arthritis (PsA), improves both joint and skin symptoms.